Lockdown Shoulder Stabilisation System (LSSS)
Clinically Proven Acromioclavicular Joint (ACJ) reconstruction
LockDown is a synthetic device used in acromioclavicular reconstruction to replace the ligament and recreate the anatomy. The device is made of double braided polyester. There are over 3,000 implantations being made every year worldwide. LockDown allows early mobilisation at 2 weeks, quick rehabilitation – with light exercise at 8 weeks and contact sport at 12 weeks.
SURGICAL TECHNIQUE
INDICATIONS
- Acromioclavicular dislocation (acute & chronic)
- Rockwood Type III, IV & V acromioclavicular joint injury
- Lateral clavicle fractures
- Revision of a previous stabilisation procedure such as a failed Weaver Dunn
- LockDown LSSS for ACJ reconstruction, was originally launched as ‘Surgilig’ in 2004 and part of a company dating back to 1924 with an impressive pedigree in innovation borne out of collaboration with clinicians. It was developed by Prof. Angus Wallace and team in Nottingham University Hospital. The name was changed from ‘Surgilig’ to ‘LockDown’ in 2011, as part of FDA approval process.
- Over 40,000 LockDown Ligaments have been implanted to date worldwide.
- The system boasts more than 20 years of clinical evidence, combined with exceptional patient outcomes, backed up by worldwide clinical use.
- Straightforward reproducible surgical technique with simple instrumentation.
- Used for acute and chronic AC injuries. Grade III, IV and V Rockwood score.
CLINICAL STUDIES
Download Clinical Study Compendium
The system boasts more than 20 years of clinical evidence, combined with exceptional patient outcomes, backed up by worldwide clinical use, with thousands of the device implanted each year.
CONTACT US TODAY